Canonical and Non-Canonical Barriers Facing AntimiR Cancer Therapeutics

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|20|29|3582-3593

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.20, Iss.29, 2013-09, pp. : 3582-3593

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-Canonical Peptides Bound to MHC

By  

Current Pharmaceutical Design, Vol. 15, Iss. 28, 2009-10 ,pp. : 3274-3282

Bentham Science Publishers

Access to resources Recommend Favorite

Non-canonical IKKs, IKKε and TBK1, as novel therapeutic targets in the treatment of non-small cell lung cancer

By Kim Jae-Young   Beg Amer A   Haura Eric B  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 10, 2013-10 ,pp. : 1109-1112

Informa Healthcare

Access to resources Recommend Favorite

The Hypomethylation Agent Bisdemethoxycurcumin Acts on the WIF-1 Promoter, Inhibits the Canonical Wnt Pathway and Induces Apoptosis in Human Non-Small-Cell Lung Cancer

By  

Current Cancer Drug Targets, Vol. 11, Iss. 9, 2011-11 ,pp. : 1098-1110

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense?

By Amodeo Valeria   Bazan Viviana   Fanale Daniele   Insalaco Lavinia   Caruso Stefano   Cicero Giuseppe   Bronte Giuseppe   Rolfo Christian   Santini Daniele   Russo Antonio  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 11, 2013-11 ,pp. : 1249-1261

Informa Healthcare

Access to resources Recommend Favorite

The Canonical Wnt Signaling Pathway in Autism

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 5, 2014-06 ,pp. : 765-770

Bentham Science Publishers

Access to resources Recommend Favorite